3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Prostatic Neoplasms
2
Neoplasm, Residual
2
Lymphoma
2
Esophageal Stenosis
2
Prostate Cancer Metastatic
1
Polycystic Ovary Syndrome
1
Myasthenia Gravis
1
Metastatic Castration-Resistant Prostate Cancer
1
Mediastinal Neoplasms
1
Lymphoma, Large-Cell, Anaplastic
1
Infertility
1
Hodgkin Disease
1
Hemangioma
1
Esophageal Neoplasms
1
Burkitt Lymphoma
1
Barrett Esophagus
1
Adrenal Insufficiency
1
Interventions
Esomeprazole
3
rofecoxib
1
Prednisolone
1
Omeprazole
1
Lansoprazole
1
Gastropexy
1
Fundoplication
1
Docosahexaenoic Acids
1
Dexlansoprazole
1
Cryotherapy
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Barrett Esophagus
×
Prednisolone
×
Clear all
NCT02004782
2025-03-27
BERST
Western Sydney Local Health District
Phase 4
Withdrawn